ArticleEClinicalMedicine2025

Efficacy and safety of the HIV-1 maturation inhibitor GSK3640254 plus two NRTIs in adults naive to antiretroviral therapy (DOMINO): 24-week results from a randomised phase 2b study.

Samit R Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.